Back to top
more

Cross Country Healthcare (CCRN)

(Delayed Data from NSDQ)

$12.53 USD

12.53
403,582

-0.57 (-4.35%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $12.56 +0.03 (0.24%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 20% (196 out of 246)

Industry: Staffing Firms

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Republic Services (RSG) Stock Up 16.4% in a Year: Here's Why

by Zacks Equity Research

Consecutive better-than-expected top and bottom-line performances, and shareholder-friendly moves have been aiding Republic Services??? (RSG) stock.

Zacks Equity Research

Reasons to Retain TransUnion (TRU) Stock in Your Portfolio

by Zacks Equity Research

TransUnion's (TRU) addressable market includes the burgeoning Big Data and analytics market.

Zacks Equity Research

Cross Country Healthcare (CCRN) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Cross Country Healthcare (CCRN) closed at $18.83, marking a +1.02% move from the previous day.

Zacks Equity Research

Omnicom (OMC) Announces Strategic Partnership With Instacart

by Zacks Equity Research

Through the collaboration, Omnicom (OMC) and Instacart can help brands understand which products suit their audiences through basket analysis and assessment of content consumption trends.

Zacks Equity Research

Automatic Data Processing (ADP) Up 6% in a Year: Here's Why

by Zacks Equity Research

The Automatic Data Processing (ADP) stock has been benefiting from consecutive better-than-expected top and bottom-line performances and encouraging guidance.

Zacks Equity Research

Wall Street Analysts Predict a 93% Upside in Cross Country (CCRN): Here's What You Should Know

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 93.1% in Cross Country (CCRN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Equity Research

Here's Why Investors Should Buy FTI Consulting (FCN) Stock Now

by Zacks Equity Research

Investor-friendly steps and a strong balance sheet are aiding FTI Consulting (FCN) stock.

Zacks Equity Research

Cross Country (CCRN) Stock Jumps 7.1%: Will It Continue to Soar?

by Zacks Equity Research

Cross Country (CCRN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

6 Reasons You Should Invest in Avis Budget (CAR) Stock Now

by Zacks Equity Research

Avis Budget (CAR) continues to benefit from acquisitions, technology enhancement and fleet expansion.

Zacks Equity Research

Reasons Why Investors Should Retain Verisk (VRSK) Stock For Now

by Zacks Equity Research

Verisk's (VRSK) growth strategy focuses on organic growth, product development and acquisitions.

Zacks Equity Research

DocuSign (DOCU) Gains From eSignature Strength Amid Expense Woes

by Zacks Equity Research

DocuSign (DOCU) remains focused on continuously acquiring eSignature customers, expanding eSignature use cases within existing customers and improving its offerings.

Zacks Equity Research

Reasons to Retain Trane Technologies' (TT) Stock For Now

by Zacks Equity Research

Trane Technologies (TT) has a consistent record of rewarding its shareholders through dividend payments and share repurchases.

Zacks Equity Research

Here's Why You Should Hold WEX Stock in Your Portfolio For Now

by Zacks Equity Research

Acquisitions are contributing significantly to WEX's revenue growth and enhancing the latter's scalability.

Zacks Equity Research

The Zacks Analyst Blog Highlights Avnet, Cross Country Healthcare, Hudson Global and Tenaris

by Zacks Equity Research

Avnet, Cross Country Healthcare, Hudson Global and Tenaris have been included in this Analyst Blog.

Zacks Equity Research

Here's Why You Should Retain Interpublic (IPG) Stock for Now

by Zacks Equity Research

Solid shareholder-friendly activities and strong liquidity boost Interpublic (IPG). However, seasonality in business is a bane.

Zacks Equity Research

Here's Why You Should Hold FLEETCOR (FLT) in Your Portfolio

by Zacks Equity Research

The recent acquisition of Levarti strengthens FLEETCOR's (FLT) airline-lodging business that reserves multiple hotel rooms for global airlines' crews and disrupted passengers every year.

Zacks Equity Research

Paychex (PAYX) Stock Up 12.3% in a Year: What's Behind It?

by Zacks Equity Research

Paychex (PAYX) stock has been benefiting from consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance.

Sejuti Banerjea headshot

What Is a Safe Stock?

by Sejuti Banerjea

Inflation is atop everyone's mind as the Fed readies for a 50 (or 75, or...?) basis-point increase in the Fed funds interest rate.

Zacks Equity Research

Here's Why You Should Retain Robert Half (RHI) Stock For Now

by Zacks Equity Research

Robert Half (RHI) benefits from a solid balance sheet and Protiviti.

Zacks Equity Research

Reasons to Retain FactSet (FDS) Stock in Your Portfolio

by Zacks Equity Research

The recent acquisition of CUSIP Global Services is expected to significantly boost FactSet's (FCN) open data strategy and expand its position in the global capital markets.

Zacks Equity Research

Here's Why You Should Retain Broadridge (BR) in Portfolio Now

by Zacks Equity Research

Broadridge (BR) rides on strategic takeovers and a solid business model. However, balance-sheet weakness is a headwind.

Zacks Equity Research

6 Reasons Why Investors Should Buy Genpact (G) Stock Now

by Zacks Equity Research

Acquisitions have helped Genpact (G) expand its portfolio and gain new domain expertise. Artificial Intelligence offers the company solid growth opportunities.

Zacks Equity Research

4 Reasons to Buy Cross Country Healthcare (CCRN) Stock Now

by Zacks Equity Research

Cross Country Healthcare (CCRN) is currently benefiting from its investments in headcount and technology.

Zacks Equity Research

Cross Country Healthcare (CCRN) Stock Moves -0.65%: What You Should Know

by Zacks Equity Research

Cross Country Healthcare (CCRN) closed the most recent trading day at $18.48, moving -0.65% from the previous trading session.

Zacks Equity Research

FLEETCOR (FLT) Announces Plan to Buy UK-Based Global Reach Group

by Zacks Equity Research

The acquisition strengthens FLEETCOR's (FLT) global position as a non-bank cross-border provider of payments by increasing its scale of the same.